Fulgent Therapeutics LLC, a leading player in the biotechnology sector, is headquartered in the United States and operates across various regions, focusing on advanced genomic testing and diagnostics. Founded in 2016, the company has rapidly established itself as a pioneer in the field, offering a comprehensive suite of services that includes genetic testing, next-generation sequencing, and custom assay development. Fulgent's core products are distinguished by their high accuracy and rapid turnaround times, catering to both clinical and research applications. The company has achieved significant milestones, including partnerships with healthcare providers and institutions, enhancing its market position as a trusted provider of innovative genomic solutions. With a commitment to advancing precision medicine, Fulgent Therapeutics continues to make strides in transforming patient care through cutting-edge technology and personalised diagnostics.
We don't have data for Fulgent Therapeutics LLC, but we can show you information about their parent organization instead.
View parent company